Hypochlorous acid as an antiseptic in the care of patients with suspected COVID-19 infection.
Arch Soc Esp Oftalmol (Engl Ed)
; 97(2): 77-80, 2022 Feb.
Article
in English
| MEDLINE | ID: covidwho-1693058
ABSTRACT
PURPOSE:
The SARS-CoV-2 virus, which causes COVID-19 disease, is transmitted by aerosols or by contact with infected surfaces. The route of entry to the body is through the nasal, oral or conjunctival mucosa. Health workers must use effective protection measures against the entry of the virus into mucous membranes, both physical and antiseptic filters. There is an antiseptic used in Ophthalmology that we believe could have virucidal action against the SARS-CoV-2 virus, formulated based on 0.01% hypochlorous acid.METHODS:
An exhaustive search has been carried out in the databases of Pubmed and Web of Science to identify relevant articles on the virucidal activity of hypochlorous acid in different concentrations until October 4, 2020.RESULTS:
There is evidence of the virucidal efficacy of 0.01% hypochlorous acid against SARS-CoV-2. According to the different scientific publications reviewed, hypochlorous acid has virucidal efficacy against different viruses, among them, SARS-CoV-2.CONCLUSIONS:
The 0.01% hypochlorous acid could act as an effective antiseptic against SARS-CoV-2, exerting a barrier on the mucosa to prevent COVID-19 infection. It can be used on the eyes, nose and mouth. We consider it necessary to assess its use in the protocol for patient health care in ophthalmology consultations, as well as to recommend its use to the general population to reduce viral load and/or prevent transmission of infection. Additional in vivo studies would be required to confirm its antiseptic action.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Anti-Infective Agents, Local
Type of study:
Reviews
Limits:
Humans
Language:
English
Journal:
Arch Soc Esp Oftalmol (Engl Ed)
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS